ADEF
ALAB icon

ABS Direct Equity Fund’s Astera Labs ALAB Stock Holding History

ABS Direct Equity Fund’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$483K Buy
+2,400
New +$342K 0.37% 45

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

ABS Direct Equity Fund's ALAB Position: Q1 2026 in Review

ABS Direct Equity Fund opened a new position in Astera Labs (ALAB) in Q1 2026: 2,400 shares worth $483K. The stake represents 0.37% of the portfolio and ranks #45 among its holdings.

703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • ABS Direct Equity Fund held 2,400 shares of Astera Labs worth $483K as of Q1 2026.
  • Astera Labs was a new ABS Direct Equity Fund position in Q1 2026.
  • Astera Labs made up 0.37% of ABS Direct Equity Fund's portfolio in Q1 2026, its #45 holding.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on ABS Direct Equity Fund's 13F filing for Q1 2026, filed 15 May 2026.